BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype

por Fettke, Heidi, Dai, Chao, Kwan, Edmond M., Zheng, Tiantian, Du, Pan, Ng, Nicole, Bukczynska, Patricia, Docanto, Maria, Kostos, Louise, Foroughi, Siavash, Brown, Stephen, Graham, Lisa-Jane K., Mahon, Kate, Horvath, Lisa G., Jia, Shidong, Kohli, Manish, Azad, Arun A.
Publicado 2023

Treatment of fecal impaction in children using combined polyethylene glycol and sodium picosulphate

por Lamanna, Anthony, Dughetti, Lauren D, Jordan‐Ely, Julie A, Dobson, Kyla M, Dynan, Megan, Foo, Adeline, Kooiman, Louise M P, Murakami, Naomi, Fiuza, Kaic, Foroughi, Siavash, Leal, Marcelo, Vidmar, Suzanna, Catto‐Smith, Anthony G, Hutson, John M, Southwell, Bridget R
Publicado 2018

Whole blood GRHL2 expression as a prognostic biomarker in metastatic hormone-sensitive and castration-resistant prostate cancer

por Kwan, Edmond M., Fettke, Heidi, Crumbaker, Megan, Docanto, Maria M., To, Sarah Q., Bukczynska, Patricia, Mant, Andrew, Ng, Nicole, Foroughi, Siavash, Graham, Lisa-Jane K., Haynes, Anne-Maree, Azer, Sarah, Lim, Lisi Elizabeth, Segelov, Eva, Mahon, Kate, Davis, Ian D., Parente, Phillip, Pezaro, Carmel, Todenhöfer, Tilman, Sathianathen, Niranjan, Hauser, Christine, Horvath, Lisa G., Joshua, Anthony M., Azad, Arun A.
Publicado 2021